跳至主要内容
临床试验/NCT03508518
NCT03508518终止不适用

Improving Access to Psychiatric Care and the Fluidity of Care Pathways for Patients Suffering From Mental Disorders in Primary Care in France: Evaluation of a Psychiatric Consultation-liaison System

University Hospital, Toulouse2 个研究点 分布在 1 个国家目标入组 151 人开始时间: 2018年8月28日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
151
试验地点
2
主要终点
Number of patients who had access to a consultation with a psychiatrist

研究概览

简要总结

Getting a consultation with a psychiatrist within an appropriate time is one of the main issues reported by general practitioners (GP) for patients suffering from mental disorders in primary care. Consultation liaison in psychiatry is a system focused on general medicine-psychiatry collaboration. The aim of the present study is to evaluate the impact of the consultation-liaison on the adequacy of the access time to a psychiatric consultation according to the degree of urgency evaluated by the GP.

详细描述

Faced with the saturation of the psychiatric care system, who recognizes the key role of the GP in mental health. Three-quarters of prescriptions for antidepressants and anxiolytics are performed by GPs, but less than one in four people with depression have been diagnosed and treated appropriately. The GPs describe difficulties in accessing psychiatric professionals and in particular to obtain a quick consultation with a psychiatrist. In different countries, psychiatric consultation-liaison (CL), centered on the collaboration of general medicine and psychiatry, have emerged. Two meta-analyzes and a Cochrane review were conducted on CL but no clinical trials were conducted in France. CL seems to improve patients' health at 3 months as well as their satisfaction and adherence to care. Results regarding the improvement of prescriptions from GP are encouraging. Better clinical trials are being requested and a need for medico-economic studies is also identified.

In France, a psychiatry CL was born in Toulouse in 2017, the "DSPP". The present study plans a 2 groups randomized clinical trial, one group of GPs having access to DSPP, the other not. For a period of 3 months, the GPs propose to any patient, for whom they want a psychiatric consultation, to participate in the study and address him/her to a psychiatrist. The DSPP is an evaluation center without long-term patient follow-up. Only patient referred by his/her GP can get into the DSPP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 15 years patient or older:
  • presenting mental suffering or a frequent or severe mental disorder
  • having consulted his GP who ask for psychiatric consultation
  • having given its consent for the use of its medico-administrative data
  • affiliated with the general health insurance scheme
  • of which the GP is from Haute Garonne and is voluntary to participate in the study
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research) and by one of the parents for minor participants

排除标准

  • Patient with ongoing psychiatric follow-up
  • Patient unable to answer questionnaires (unable to read or write)
  • Patients receiving a measure of legal protection

结局指标

主要结局

Number of patients who had access to a consultation with a psychiatrist

时间窗: 2 to 21 working days after inclusion

Number of patients who had access to a consultation with a psychiatrist within 2 working days following the GP consultation for patients whose GP wishes an "urgent" consultation, within 7 working days for a "quick" consultation and within 21 working days for a "non-urgent" consultation.

次要结局

  • Number of passages to psychiatric emergencies(6 months)
  • Number of suicide attempts(6 months)
  • Duration of prescription of different drugs(date of inclusion, 1 month and 6 months after inclusion)
  • Evaluation of compliance with antidepressant prescriptions(date of inclusion, 1 month and 6 months after inclusion)
  • Mental health status by Patient Health Questionnaire (PHQ)(date of inclusion, 1 month and 6 months after inclusion)
  • Number of days between M0 (GP consultation) and M1 (psychiatric consultation)(6 months)
  • Employment status(6 months)
  • Patient satisfaction(1 month)
  • Quality of life with EuroQol scale(6 months)
  • Cost-Effectiveness Ratios of Patient Management Strategies(6 months)
  • Mental health status by Symptom Checklist (SCL)(date of inclusion, 1 month and 6 months after inclusion)
  • Number of prescription treatment of mental disorders(date of inclusion, 1 month and 6 months after inclusion)
  • Incremental Cost-Utility(6 months)
  • GP satisfaction(6 months)
  • Production costs(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Improving Access to Psychiatric Care for Patients in... | 临床试验